Hattori, Yosuke <br/><br/>
A selective estrogen receptor modulator inhibits tumor necrosis factor-α-induced apoptosis through the ERK1/2 signaling pathway in human chondrocytes.  [electronic resource] 

 -  Biochemical and biophysical research communications  May 2012 
 - 418-24 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1090-2104 
<br/><br/><label>Standard No.: </label>10.1016/j.bbrc.2012.03.111  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Survival<br/>Chondrocytes--drug effects<br/>Enzyme Activation<br/>Humans<br/>MAP Kinase Kinase 4--biosynthesis<br/>MAP Kinase Signaling System<br/>Mitogen-Activated Protein Kinase 1--biosynthesis<br/>Mitogen-Activated Protein Kinase 3--biosynthesis<br/>Proto-Oncogene Proteins c-akt--biosynthesis<br/>RNA, Small Interfering--genetics<br/>Raloxifene Hydrochloride--pharmacology<br/>Selective Estrogen Receptor Modulators--pharmacology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>p38 Mitogen-Activated Protein Kinases--biosynthesis